Viral infections and pediatric liver transplantation

Michael Green1

  • 1University of Pittsburgh School of Medicine, Division of Allergy, Immunology and Infectious Diseases, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA. greenm@chplink.chp.edu

Insights

Viral infections cause significant illness and death in children after liver transplants (LTx). Improved management of known viruses and research into new ones are enhancing patient outcomes and prevention strategies.

Area of Science:

  • Pediatric Hepatology
  • Transplant Infectious Diseases
  • Virology

Background:

  • Viral infections are a major complication in pediatric liver transplant (LTx) recipients, contributing to significant morbidity and mortality.
  • Management strategies for both donor-associated and community-acquired viruses have advanced.
  • The emergence of novel viral pathogens poses an ongoing challenge in this population.

Purpose of the Study:

  • To review the current understanding of viral infections following pediatric liver transplantation.
  • To highlight advancements in the prevention and treatment of viral infections in LTx recipients.
  • To discuss the implications of emerging viral pathogens in pediatric liver transplant care.

Main Methods:

  • Literature review of viral infections in pediatric liver transplant patients.
  • Analysis of current data on viral epidemiology and clinical outcomes.
  • Discussion of established and emerging viral pathogens and their management.

Main Results:

  • Increased clinical experience has led to improved outcomes for children undergoing LTx.
  • Effective preventive strategies are being developed for common viral infections.
  • Ongoing research is crucial for understanding and managing newly recognized viral pathogens.

Conclusions:

  • Optimized management of viral infections is critical for improving survival rates in pediatric liver transplant recipients.
  • Continued research into emerging viral threats is necessary to develop future treatments and preventive measures.
  • A comprehensive approach to viral surveillance and management is essential in pediatric LTx programs.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...